Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.130
+0.010 (0.47%)
May 30, 2025, 4:00 PM - Market closed
Stereotaxis Employees
Stereotaxis had 139 employees as of December 31, 2024. The number of employees increased by 17 or 13.93% compared to the previous year.
Employees
139
Change (1Y)
17
Growth (1Y)
13.93%
Revenue / Employee
$197,914
Profits / Employee
-$191,741
Market Cap
183.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
STXS News
- 20 days ago - Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Stereotaxis Reports 2025 First Quarter Financial Results - GlobeNewsWire
- 5 weeks ago - Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025 - GlobeNewsWire
- 5 weeks ago - Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025 - GlobeNewsWire
- 2 months ago - Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program - GlobeNewsWire
- 2 months ago - Stereotaxis to Present at 37th Annual Roth Conference - GlobeNewsWire
- 3 months ago - Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn - Seeking Alpha
- 3 months ago - Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript - Seeking Alpha